Tiedemann Advisors, LLC Mimedx Group, Inc. Transaction History

Tiedemann Advisors, LLC

$2.31 Billion
Q3 2023

A detailed history of Tiedemann Advisors, LLC transactions in Mimedx Group, Inc. stock. As of the latest transaction made, Tiedemann Advisors, LLC holds 113,376 shares of MDXG stock, worth $769,823. This represents 0.04% of its overall portfolio holdings.

Number of Shares

113,376

Previous 10,422 987.85%

Holding current value

$769,823

Previous $68,000 1114.71%

% of portfolio

0.04%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$6.35 - $8.16 $653,757 - $840,104	102,954 Added 987.85%	113,376 $826,000
Q1 2022 Apr 27, 2022	BUY	$4.27 - $6.27 $44,501 - $65,345	10,422 New	10,422 $49,000
Q3 2021 Nov 12, 2021	SELL	$5.52 - $15.83 $2.45 Million - $7.03 Million	-444,033 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$9.02 - $12.72 $7,937 - $11,193	-880 Reduced 0.2%	444,033 $5.56 Million
Q4 2020 Feb 16, 2021	BUY	$5.32 - $10.17 $2.37 Million - $4.52 Million	444,913 New	444,913 $4.04 Million

Q4 2018 Feb 13, 2019	SELL	$1.15 - $6.45 $1.67 Million - $9.37 Million	-1,452,418 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$3.22 - $6.33 $805 - $1,582	-250 Reduced 0.02%	1,452,418 $8.98 Million
Q2 2018 Aug 14, 2018	BUY	$5.39 - $8.96 $1,347 - $2,240	250 Added 0.02%	1,452,668 $9.28 Million
Q4 2017 Feb 14, 2018	BUY	$10.87 - $13.9 $15.3 Million - $19.6 Million	1,406,746 Added 3080.11%	1,452,418 $18.3 Million
Q3 2017 Nov 28, 2017	SELL	$11.86 - $17.34 $18.1 Million - $26.5 Million	-1,529,203 Reduced 97.1%	45,672 $392,000
Q3 2017 Nov 13, 2017	SELL	$11.86 - $17.34 $22,308 - $32,616	-1,881 Reduced 0.12%	1,574,875 $18.5 Million
Q2 2017 Aug 14, 2017	BUY	N/A	1,576,756	1,576,756 $23.6 Million

Others Institutions Holding MDXG

# of Institutions

218

Shares Held

94.7M

Call Options Held

221K

Put Options Held

77.4K

View Full List

About MIMEDX GROUP, INC.

Ticker MDXG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 113,609,000
Market Cap $771M
Description
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...

More about MDXG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tiedemann Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tiedemann Advisors, LLC with notifications on news.

Account

Tiedemann Advisors, LLC Mimedx Group, Inc. Transaction History